Utrophin correlates with disease severity in Duchenne muscular dystrophy

被引：2

作者：

Guiraud, Simon ^{[1
,2
]}

Davies, Kay ^{[3
]}

机构：

[1] Paris Saclay Univ, END ICAP Lab, UVSQ, INSERM,UMR1179, F-78000 Versailles, Paris, France

[2] SQY Therapeut, F-78180 Montigny, France

[3] Univ Oxford, MDUK Oxford Neuromuscular Ctr, Dept Physiol Anat & Genet, Oxford OX1 3PT, England

来源：

MED | 2023年 / 4卷 / 04期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1016/j.medj.2023.03.005

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

This month in Med, the description of an unusually severely affected DMD patient suffering from a large deletion in the dystrophin gene confirms that absence of utrophin worsens the dystrophy and supports the concept that utrophin upregulation ameliorates the pathology. This study may guide the development of dystrophin-based gene therapies.

引用

页码：220 / 222

页数：3

共 50 条

[21] Discovery of small molecule utrophin modulators for the therapy of Duchenne muscular dystrophy
Wynne, G.
Vuorinen, A.
Emer, E.
Conole, D.
Chatzopoulou, M.
Davies, S.
Russell, A.
Guiraud, S.
Squire, S.
Berg, A.
Edwards, B.
Hemming, S.
Kennedy, T.
Moir, L.
Davies, K.
Harriman, S.
Tinsley, J.
Wilson, F.
NEUROMUSCULAR DISORDERS, 2017, 27 : S189 - S189
[22] Relationship between utrophin and regenerating muscle fibers in duchenne muscular dystrophy
Shim, JY
Kim, TS
YONSEI MEDICAL JOURNAL, 2003, 44 (01) : 15 - 23
[23] Utrophin gene transfer is a promising option for treating Duchenne Muscular Dystrophy
Gilbert, R
Nalbantoglu, J
Petrof, BJ
Massie, B
Tinsley, JM
Davis, KE
Karpati, G
NEUROLOGY, 1998, 50 (04) : A324 - A324
[24] Disease course in mdx:utrophin(+/-) mice: comparison of three mouse models of Duchenne muscular dystrophy
McDonald, Abby A.
Hebert, Sadie L.
Kunz, Matthew D.
Ralles, Steven J.
McLoon, Linda K.
PHYSIOLOGICAL REPORTS, 2015, 3 (04):
[25] The abnormal expression of utrophin in Duchenne and Becker muscular dystrophy is age related
Taylor, J
Muntoni, F
Dubowitz, V
Sewry, CA
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1997, 23 (05) : 399 - 405
[26] Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy
Deconinck, AE
Rafael, JA
Skinner, JA
Brown, SC
Potter, AC
Metzinger, L
Watt, DJ
Dickson, JG
Tinsley, JM
Davies, KE
CELL, 1997, 90 (04) : 717 - 727
[27] Small molecule utrophin modulators for the therapy of Duchenne muscular dystrophy (DMD)
Russell, Angela
Vuorinen, Aini
Willis, Nicky
Conole, Daniel
Chatzopoulou, Maria
Emer, Enrico
Wilkinson, Isabel
Davies, Stephen
Guiraud, Simon
Squire, Sarah
Babbs, Arran
Dugdale, Hannah
Edwards, Ben
Hemming, Sarah
Moir, Lee
Perkins, Kelly
Harriman, Shawn
Wilson, Francis
Wynne, Graham
Tinsley, Jon
Davies, Kay
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
[28] Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy
Zaharieva, Irina T.
Calissano, Mattia
Scoto, Mariacristina
Preston, Mark
Cirak, Sebahattin
Feng, Lucy
Collins, James
Kole, Ryszard
Guglieri, Michela
Straub, Volker
Bushby, Kate
Ferlini, Alessandra
Morgan, Jennifer E.
Muntoni, Francesco
PLOS ONE, 2013, 8 (11):
[29] ASSOCIATION OF TOTAL ANNUAL COSTS OF DUCHENNE MUSCULAR DYSTROPHY WITH DISEASE SEVERITY
Vavrovsky, A.
VALUE IN HEALTH, 2022, 25 (12) : S90 - S90
[30] Pulmonary function tests for evaluating the severity of Duchenne muscular dystrophy disease
Levine, Hagit
Goldfarb, Itai
Katz, Julia
Carmeli, Moriah
Shochat, Tzippy
Mussaffi, Huda
Aharoni, Sharon
Prais, Dario
Nevo, Yoram
ACTA PAEDIATRICA, 2023, 112 (04) : 854 - 860

← 1 2 3 4 5 →